Treatments

Treatments

Treating Triple-Negative Breast Cancer

Treating triple-negative breast cancer (TNBC) has been notoriously difficult, but recent studies have shown success in treating before surgery. Watch as expert Dr. Peter Schmid explains.

Andrea Hutton, Peter Schmidt, MD, PhD, FRCP

Treatments

Treatments for HER2+ Breast Cancer Unveiled

New targeted treatments for HER2+ breast cancer are on the horizon, and some are FDA-approved. Watch as Dr. Sara Hurvitz explains compelling clinical trial data and what the results mean for advanced metastatic breast cancer patients.

Andrea Hutton, Sara A. Hurvitz, MD

Latest News

Treatments

Home Runs and Hope for HER2+

Julie Gralow, MD, Andrea Hutton

Treatments

Breast Cancer Research Announced at ASCO 2018: Do All Patients Need Chemotherapy?

Andrew Schorr, Julie Gralow, MD

Treatments

ESMO 17: Advances for Metastatic Breast Cancer Patients

Fatima Cardoso, MD

Treatments

PARP Inhibitors in BRCA-Mutated Breast Cancer

Giuseppe Curigliano, MD, PhD

Treatments

Breast Cancer Research Highlights From ASCO 2017

Steven J. Isakoff, MD, PhD, Andrew Schorr

Treatments

ASCO 2017: Breast Cancer Research News

Andrew Schorr, Julie Gralow, MD

Treatments

Expert Perspective: Hope and Progress for the Future of Breast Cancer Treatment

William Gradishar, MD, FACP

Treatments

Developing Treatment Options for BRCA-Positive Breast Cancer Patients

Julie Gralow, MD

Treatments

Clinical Trials: Improving Outcomes for Women With Metastatic Breast Cancer

Dr Martine Piccart-Gebhart

Treatments

Renate’s Story: Breast Cancer Treatment and the German Breast Cancer Association

Renate Haidinger

Treatments

Breast Cancer Survivor, Renate Haidinger, Gives Advice for Other Breast Cancer Patients

Renate Haidinger

Treatments

Towards Improving Breast Cancer Treatment

Renate Haidinger